Form 8-K - Current report:
SEC Accession No. 0001564590-22-035783
Filing Date
2022-10-31
Accepted
2022-10-31 06:02:35
Documents
12
Period of Report
2022-10-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K mnkd-8k_20221026.htm   iXBRL 8-K 29624
  Complete submission text file 0001564590-22-035783.txt   153090

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20221026.xsd EX-101.SCH 5605
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20221026_lab.xml EX-101.LAB 18569
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20221026_pre.xml EX-101.PRE 11047
6 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-8k_20221026_htm.xml XML 3401
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 221343669
SIC: 2834 Pharmaceutical Preparations